liposomal herpes simplex virus-2 glycoprotein-D vaccine (Molecular Express)

N/A

Report date: 2025/01/26 18:01:27

Base Information

Drug Nameliposomal herpes simplex virus-2 glycoprotein-D vaccine (Molecular Express)

Drug Alias NameHSV-2 vaccine (Molecular Express)LgDVac (Molecular Express)gD2-lm

ClassificationVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Recombinant polypeptideVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionT lymphocytes stimulants

TargetsNot applicable

Therapy Area/IndicationsHerpes Simplex Virus Type 2 Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMolecular Express Inc

China Registration ClassN/A

Develop Information

Active CompaniesMolecular Express Inc

Inactive CompaniesN/A

Active IndicationsHerpes Simplex Virus Type 2 Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A